The relationship between dietary intake, growth and body composition in Phenylketonuria

Maureen Evans, Helen Truby, Avihu Boneh

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Aim: Phenylketonuria (PKU) is an inborn error of protein metabolism that results from perturbation in phenylalanine hydroxylase activity leading to elevated blood levels of phenylalanine (phe). We aimed to explore the relationships between dietary patterns (total-protein, natural-protein, amino-acid formula), and the ratio of protein to energy intake with growth and body composition. Method: Longitudinal prospective data (1-6 measurements) of growth, dietary intake and body composition in patients treated with phe-restricted diet only (D-PKU; n=32), and tetrahydrobiopterin (BH4)±phe-restricted diet (BH4-PKU; n=5) were collected over a two-year period. Healthy siblings provided control data (n=21). Results: There were no significant differences in weight-, height-, BMI z-score or percent body fat mass (%fatmass) between the D-PKU, BH4-PKU and control groups or between the all-types of PKU combined and controls, which confirmed 'normal' growth in the PKU cohort. Total-protein intake in the all-types of PKU group met or exceeded WHO safe protein recommendations. There were no significant relationships between anthropometric and dietary variables. Significant negative correlations were found in body composition: %fatmass and total-protein intake (rs =-0.690, p≤0.001), natural-protein intake (rs =-0.534, p=0.001), and AAF intake (rs =-0.510, p=0.001). Age was significantly correlated with %fatmass (rs =0.493, p=0.002) A total-protein intake of 1.5-2.6g/kg/day and natural-protein intake >0.5g/kg/day were associated with improved body composition. An apparent safe P:E ratio of 3.0-4.5g protein/100kcal was strongly associated with appropriate growth outcomes. Conclusions: Clinical decision-making needs to consider both the enhancement of natural-protein tolerance and the application of an apparent 'safe' protein to energy ratio to support optimal growth and body composition in PKU.

Original languageEnglish
Pages (from-to)36-42
Number of pages7
JournalMolecular Genetics and Metabolism
Volume122
Issue number1-2
DOIs
Publication statusPublished - Sep 2017

Keywords

  • Body composition
  • Growth
  • Phenylalanine restricted diet
  • Phenylketonuria
  • Protein:Energy ratio (P:E ratio)

Cite this

@article{c394c238014a42e7b81c33a74748fd06,
title = "The relationship between dietary intake, growth and body composition in Phenylketonuria",
abstract = "Aim: Phenylketonuria (PKU) is an inborn error of protein metabolism that results from perturbation in phenylalanine hydroxylase activity leading to elevated blood levels of phenylalanine (phe). We aimed to explore the relationships between dietary patterns (total-protein, natural-protein, amino-acid formula), and the ratio of protein to energy intake with growth and body composition. Method: Longitudinal prospective data (1-6 measurements) of growth, dietary intake and body composition in patients treated with phe-restricted diet only (D-PKU; n=32), and tetrahydrobiopterin (BH4)±phe-restricted diet (BH4-PKU; n=5) were collected over a two-year period. Healthy siblings provided control data (n=21). Results: There were no significant differences in weight-, height-, BMI z-score or percent body fat mass ({\%}fatmass) between the D-PKU, BH4-PKU and control groups or between the all-types of PKU combined and controls, which confirmed 'normal' growth in the PKU cohort. Total-protein intake in the all-types of PKU group met or exceeded WHO safe protein recommendations. There were no significant relationships between anthropometric and dietary variables. Significant negative correlations were found in body composition: {\%}fatmass and total-protein intake (rs =-0.690, p≤0.001), natural-protein intake (rs =-0.534, p=0.001), and AAF intake (rs =-0.510, p=0.001). Age was significantly correlated with {\%}fatmass (rs =0.493, p=0.002) A total-protein intake of 1.5-2.6g/kg/day and natural-protein intake >0.5g/kg/day were associated with improved body composition. An apparent safe P:E ratio of 3.0-4.5g protein/100kcal was strongly associated with appropriate growth outcomes. Conclusions: Clinical decision-making needs to consider both the enhancement of natural-protein tolerance and the application of an apparent 'safe' protein to energy ratio to support optimal growth and body composition in PKU.",
keywords = "Body composition, Growth, Phenylalanine restricted diet, Phenylketonuria, Protein:Energy ratio (P:E ratio)",
author = "Maureen Evans and Helen Truby and Avihu Boneh",
year = "2017",
month = "9",
doi = "10.1016/j.ymgme.2017.07.007",
language = "English",
volume = "122",
pages = "36--42",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Elsevier",
number = "1-2",

}

The relationship between dietary intake, growth and body composition in Phenylketonuria. / Evans, Maureen; Truby, Helen; Boneh, Avihu.

In: Molecular Genetics and Metabolism, Vol. 122, No. 1-2, 09.2017, p. 36-42.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - The relationship between dietary intake, growth and body composition in Phenylketonuria

AU - Evans, Maureen

AU - Truby, Helen

AU - Boneh, Avihu

PY - 2017/9

Y1 - 2017/9

N2 - Aim: Phenylketonuria (PKU) is an inborn error of protein metabolism that results from perturbation in phenylalanine hydroxylase activity leading to elevated blood levels of phenylalanine (phe). We aimed to explore the relationships between dietary patterns (total-protein, natural-protein, amino-acid formula), and the ratio of protein to energy intake with growth and body composition. Method: Longitudinal prospective data (1-6 measurements) of growth, dietary intake and body composition in patients treated with phe-restricted diet only (D-PKU; n=32), and tetrahydrobiopterin (BH4)±phe-restricted diet (BH4-PKU; n=5) were collected over a two-year period. Healthy siblings provided control data (n=21). Results: There were no significant differences in weight-, height-, BMI z-score or percent body fat mass (%fatmass) between the D-PKU, BH4-PKU and control groups or between the all-types of PKU combined and controls, which confirmed 'normal' growth in the PKU cohort. Total-protein intake in the all-types of PKU group met or exceeded WHO safe protein recommendations. There were no significant relationships between anthropometric and dietary variables. Significant negative correlations were found in body composition: %fatmass and total-protein intake (rs =-0.690, p≤0.001), natural-protein intake (rs =-0.534, p=0.001), and AAF intake (rs =-0.510, p=0.001). Age was significantly correlated with %fatmass (rs =0.493, p=0.002) A total-protein intake of 1.5-2.6g/kg/day and natural-protein intake >0.5g/kg/day were associated with improved body composition. An apparent safe P:E ratio of 3.0-4.5g protein/100kcal was strongly associated with appropriate growth outcomes. Conclusions: Clinical decision-making needs to consider both the enhancement of natural-protein tolerance and the application of an apparent 'safe' protein to energy ratio to support optimal growth and body composition in PKU.

AB - Aim: Phenylketonuria (PKU) is an inborn error of protein metabolism that results from perturbation in phenylalanine hydroxylase activity leading to elevated blood levels of phenylalanine (phe). We aimed to explore the relationships between dietary patterns (total-protein, natural-protein, amino-acid formula), and the ratio of protein to energy intake with growth and body composition. Method: Longitudinal prospective data (1-6 measurements) of growth, dietary intake and body composition in patients treated with phe-restricted diet only (D-PKU; n=32), and tetrahydrobiopterin (BH4)±phe-restricted diet (BH4-PKU; n=5) were collected over a two-year period. Healthy siblings provided control data (n=21). Results: There were no significant differences in weight-, height-, BMI z-score or percent body fat mass (%fatmass) between the D-PKU, BH4-PKU and control groups or between the all-types of PKU combined and controls, which confirmed 'normal' growth in the PKU cohort. Total-protein intake in the all-types of PKU group met or exceeded WHO safe protein recommendations. There were no significant relationships between anthropometric and dietary variables. Significant negative correlations were found in body composition: %fatmass and total-protein intake (rs =-0.690, p≤0.001), natural-protein intake (rs =-0.534, p=0.001), and AAF intake (rs =-0.510, p=0.001). Age was significantly correlated with %fatmass (rs =0.493, p=0.002) A total-protein intake of 1.5-2.6g/kg/day and natural-protein intake >0.5g/kg/day were associated with improved body composition. An apparent safe P:E ratio of 3.0-4.5g protein/100kcal was strongly associated with appropriate growth outcomes. Conclusions: Clinical decision-making needs to consider both the enhancement of natural-protein tolerance and the application of an apparent 'safe' protein to energy ratio to support optimal growth and body composition in PKU.

KW - Body composition

KW - Growth

KW - Phenylalanine restricted diet

KW - Phenylketonuria

KW - Protein:Energy ratio (P:E ratio)

UR - http://www.scopus.com/inward/record.url?scp=85025091118&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2017.07.007

DO - 10.1016/j.ymgme.2017.07.007

M3 - Article

VL - 122

SP - 36

EP - 42

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 1-2

ER -